Biopharmaceutical company Seres Therapeutics, Inc. recently announced the implementation of a series of strategic adjustments aimed at extending its corporate operating cycle.
Show original
As an important part of the cost optimization plan, the company has decided to streamline its organizational structure and reduce its global workforce by approximately 30%. This personnel adjustment is expected to effectively lower operating expenses and secure a longer funding cycle for core R&D projects.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
United Stables: U's total supply on BNB Chain has exceeded 1 billion tokens
Odaily星球日报•2026/03/04 09:16
A trader went long on 600 BTC, with an average entry price of $70,235.8.
BlockBeats•2026/03/04 09:15
Pi Network Advances Roadmap with Protocol v19.9 Completion and v20.2 Plans
CryptoNewsFlash•2026/03/04 09:09
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$71,090.87
+6.00%
Ethereum
ETH
$2,068.7
+5.21%
Tether USDt
USDT
$1.0000
+0.01%
BNB
BNB
$652.01
+4.16%
XRP
XRP
$1.41
+4.09%
USDC
USDC
$1
-0.02%
Solana
SOL
$89.59
+5.63%
TRON
TRX
$0.2841
+0.91%
Dogecoin
DOGE
$0.09238
+2.23%
Cardano
ADA
$0.2723
+2.11%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now